Navigation Links
Elsevier to Create New Guidelines for Pharmaceutical Article Reprint, Compilation and Custom Publications
Date:6/4/2009

PHILADELPHIA, Pennsylvania, June 4 /PRNewswire-FirstCall/ --

- Company Also Updates Findings Related to Australian Sponsored Publication Practices From 2000-2005

Elsevier, a leading international publisher of scientific, technical and medical (STM) information products and services, announced today it has moved to provide consistent internal guidelines for its pharmaceutical services divisions when producing reprints, article compilations or custom publications on behalf of pharmaceutical companies. This initiative follows an internal review that was commenced when the company became aware of a series of publications produced in Australia between the years 2000 and 2005 that carried the name "journal of" but lacked proper sponsor disclosures and were not in fact journals and should not have been titled as such.

Given the issues identified in the Australasian series, the company is acting to ensure that all of its pharmaceutical services divisions around the globe are following consistent sponsorship practices and disclosure standards for various article reprint products. While these pharmaceutical services divisions frequently reprint peer reviewed articles from Elsevier, they are managed separately from the division that publishes the company's core collection of primary research journals.

Elsevier will review practices related to all article reprint, compilation or custom publications and set out guidelines on content, permission, use of imprint and repackaging to ensure that such publications are not confused with Elsevier's core peer reviewed journals and that the sponsorship of any publication is clearly disclosed. Elsevier expects to complete its review and issue guidelines by June 30, 2009.

"Full disclosure should be the standard at Elsevier, and we need to strive every day to make sure that we enforce consistent global guidelines for sponsorship and disclos
'/>"/>

SOURCE Elsevier
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Elseviers PharmaPendium(TM) Introduces the FDA Classic Collection
2. Elseviers PharmaPendium introduces the FDA Classic Collection
3. Elsevier Appoints Chris Dillon as Managing Director, Clinical Decision Support
4. Elsevier launches Epidemics -- the journal on infectious disease dynamics
5. Milestone tumor virus publication by Elsevier journal Virology
6. Elsevier Acquires Professional Development Software, Inc., Provider of Software for Nurses Online Learning Education
7. Elsevier and Brain Mapping Foundation co-host 6th Annual World Congress of IBMISPS
8. Three Prize Winners Awarded in Elseviers Article 2.0 Contest
9. Elsevier Partners With Communispace to Launch Global Online Community
10. Elsevier Announces Launch of Osteopathic Family Physician Publishing Partnership Formed With American College of Osteopathic Family Physicians
11. Elsevier Titles Win Four PROSE Awards From Association of American Publishers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013 -- Lauren Sciences, a privately-held biotechnology ... platform technology, announced today that it was independently ... with its V-Smart Platform, and selected as a ... Group. , The report, " Early ... Emerging Companies ," features companies MCD Group independently ...
(Date:6/18/2013)... are more likely to keep their scheduled medical appointments ... feel their physician listens, explains things clearly and knows ... Johns Hopkins research suggests. , "If people feel their ... feel that doctor has their best interests at heart ... says study leader Tabor E. Flickinger, M.D., M.P.H., a ...
(Date:6/18/2013)... Obama officially declared June as Lesbian, Gay, ... despite advances in civil rights, sexual minority ... suicide than their heterosexual peers, according to ... of Missouri psychology graduate student recently published ... minority youth, which could help improve psychological ...
(Date:6/18/2013)... FDA to support the need for a blood test ... University of Rochester Medical Center just added significant evidence ... that it might be clinically useful to measure two ... M.P.H., an associate professor of Emergency Medicine at URMC, ... combination of two proteins released into the bloodstream after ...
(Date:6/18/2013)... penalties on hospitals with higher-than-expected rates of 30-day ... are evaluating the most accurate methods for tracking ... in the June issue of the Journal ... that the American College of Surgeons National Surgical ... accurate data tracking than another popular database, the ...
Breaking Medicine News(10 mins):Health News:Respect may be the key to stopping patient 'no shows' 2Health News:Sexual minority youth need specialized treatment from therapists 2Health News:ACS NSQIP® data is more accurate than administrative data for tracking 30-day hospital readmissions 2Health News:ACS NSQIP® data is more accurate than administrative data for tracking 30-day hospital readmissions 3Health News:ACS NSQIP® data is more accurate than administrative data for tracking 30-day hospital readmissions 4
... a milestone in the evolution of its pioneering stem ... received a $34.9 million grant from the California Institute ... a regenerative medicine building on its campus. , The ... Rafael Violy, was approved by the UC Regents in ...
... project as innovative in terms of energy efficiency and ... awarded nearly $27 million in funding for a new ... (USC). USC was one of 12 California institutions considered ... million to build stem cell research facilities throughout California. ...
... The University of Alabama at Birmingham (UAB) this ... a speedier cancer radiation therapy. The new technique can ... for selected patients. , Additionally, the new therapy saves ... that are the same or better than other radiotherapy ...
... SAN CARLOS, Calif., May 7 Nektar Therapeutics,(Nasdaq: NKTR ... ended March 31, 2008., Cash, cash equivalents, and short-term ... million at December 31, 2007., Nektar reported a net ... quarter of 2008, compared to a net loss of $25.7 ...
... PHILADELPHIA, May 7 Kappa Alpha Psi Fraternity, Inc.,announced ... the St.,Jude Children,s Research Hospital and their work to ... the St. Jude Children,s Research,Hospital in Memphis, TN, May ... Fraternity, Inc., has taken on the,awesome responsibility of sponsoring ...
... 7 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals,a developer and manufacturer ... announced the appointment of David B. Holtz as ... 2008. In these,roles, Mr. Holtz will be responsible ... and Information Technology reporting to,Thomas E. Gardner, Chairman ...
Cached Medicine News:Health News:UCSF receives funding for building from California stem cell agency 2Health News:UCSF receives funding for building from California stem cell agency 3Health News:USC receives nearly $27 million in funding for new stem cell research facility 2Health News:UAB first in US to offer speedier precise cancer radiotherapy 2Health News:Nektar Therapeutics Announces First Quarter 2008 Results 2Health News:Nektar Therapeutics Announces First Quarter 2008 Results 3Health News:Nektar Therapeutics Announces First Quarter 2008 Results 4Health News:Nektar Therapeutics Announces First Quarter 2008 Results 5Health News:Nektar Therapeutics Announces First Quarter 2008 Results 6Health News:Nektar Therapeutics Announces First Quarter 2008 Results 7Health News:Nektar Therapeutics Announces First Quarter 2008 Results 8Health News:Kappa Alpha Psi Fraternity Celebrates St. Jude Partnership 2Health News:Kappa Alpha Psi Fraternity Celebrates St. Jude Partnership 3Health News:NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer 2Health News:NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer 3Health News:NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer 4
(Date:6/18/2013)... 2013 New-generation electronic designs are focused ... lightweight. Simultaneously, circuitry is increasing the number of ... which it performs at. Connecting cables from the ... equipment, such as cameras or detectors, must be ... connectors include custom cable designs for high-quality signal ...
(Date:6/18/2013)... EMERYVILLE, Calif. , June 18, 2013 ... today from a Phase 2/3 clinical trial of ... statistically significant improvement in levodopa-induced dyskinesia (LID) as ... versus placebo in the Unified Dyskinesia Rating Scale ... amantadine intended for once-nightly administration that is being ...
(Date:6/18/2013)... 2013   Polymer Technology Systems, Inc. ... Group to integrate the CardioChek ® ... by health systems across the country. The CardioChek ... distributed through Hanson Medical Systems , offers ... LDL cholesterol, triglycerides, and glucose. (Logo: ...
Breaking Medicine Technology:Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3
... /PRNewswire-Asia/ -- Neusoft Corporation ("Neusoft", 600718.SH), a leading ... announced that its wholly-owned subsidiary Neusoft Europe Inc. ... Aerotel Medical Systems Ltd. ("Aerotel"), a leading global ... and telecare solutions based in Israel, under which ...
... Leading events organiser UBM Live is today ... ICSE, P-MEC and BioPh Japan events in Tokyo as a ... have now been rescheduled and will be held from 13-15 ... business community is intent on picking itself up as quickly ...
Cached Medicine Technology:Neusoft to Invest in Israeli Medical Solutions Company for Accelerating Expansion in Global Healthcare Service Market 2Boost For Japanese Pharma Market as UBM Announces Rescheduled Japan Pharma and Bio Events 2Boost For Japanese Pharma Market as UBM Announces Rescheduled Japan Pharma and Bio Events 3
The Linvatec 3mm and 5mm Universal Light Guides are autoclavable. They offer flexibility, superior light transmission, and universal fittings in a lightweight package....
ACMI™ offers an assortment of fiberoptic light guides, high transmission autoclavable fiberoptic light guides, and light guide adapters to connect our scopes to other manufacturers' light sourc...
ACMI™ offers an assortment of fiberoptic light guides, high transmission autoclavable fiberoptic light guides, and light guide adapters to connect our scopes to other manufacturers' light sourc...
... EndoEYE offers a revolutionary ... places a miniaturized CCD chip ... making fragile rod lenses a ... puts your eye right at ...
Medicine Products: